Organically modified silica nanoparticles as drug delivery vehicles in photodynamic therapy

被引:8
作者
Gupta, Anurag [1 ]
Goswami, Lalit N. [1 ]
Ethirajan, Manivannan [1 ]
Missert, Joseph [1 ]
Rao, K. V. R. [1 ]
Ohulchanskyy, Tymish [2 ]
Roy, Indrajit [2 ]
Morgan, Janet
Prasad, Paras N. [2 ]
Pandey, Ravindra K. [1 ]
机构
[1] Roswell Pk Canc Inst, Photodynam Therapy Ctr, Buffalo, NY 14263 USA
[2] SUNY Buffalo, Inst Lasers Photon & Biophoton, Buffalo, NY 14214 USA
关键词
organically modified silica nanoparticles; photosensitizer; photodynamic therapy; PYROPHEOPHORBIDE-A; PHOTOSENSITIZERS; PHARMACOKINETICS; NANOMEDICINE; DERIVATIVES;
D O I
10.1142/S1088424611003306
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
To investigate the effect of hydrophobicity, charge and size of photosensitizers (PS) on their encapsulation efficiency in organically modified silica nanoparticles (ORMOSIL), a series of alkyl ether analogs of 2-(1'-hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH) containing varied number of carbon units, HPPH with anionic and cationic functionalities, and HPPH analogs with molecular weight ranging from similar to 630 to 6000 Daltons were synthesized. Our preliminary results suggest that these factors play a significant role in encapsulation of the photosensitizers and their release from ORMOSIL nanoparticles. The synthesis and characterization of PS-encapsulated ORMOSIL and a comparative study on the effect of PS size, lipophilicity and charge on encapsulation efficiency, photophysical characteristics and release kinetics are discussed.
引用
收藏
页码:401 / 411
页数:11
相关论文
共 24 条
[1]   Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy [J].
Bellnier, DA ;
Greco, WR ;
Nava, H ;
Loewen, GM ;
Oseroff, AR ;
Dougherty, TJ .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (01) :40-45
[2]   MURINE PHARMACOKINETICS AND ANTITUMOR EFFICACY OF THE PHOTODYNAMIC SENSITIZER 2-[1-HEXYLOXYETHYL]-2-DEVINYL PYROPHEOPHORBIDE-A [J].
BELLNIER, DA ;
HENDERSON, BW ;
PANDEY, RK ;
POTTER, WR ;
DOUGHERTY, TJ .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 1993, 20 (01) :55-61
[3]  
Bellnier DA, 2003, CANCER RES, V63, P1806
[4]   Irradiance-dependent photobleaching and pain in δ-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas [J].
Cottrell, William J. ;
Paquette, Anne D. ;
Keymel, Kenneth R. ;
Foster, Thomas H. ;
Oseroff, Allan R. .
CLINICAL CANCER RESEARCH, 2008, 14 (14) :4475-4483
[5]   Photodynamic therapy [J].
Dougherty, TJ ;
Gomer, CJ ;
Henderson, BW ;
Jori, G ;
Kessel, D ;
Korbelik, M ;
Moan, J ;
Peng, Q .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (12) :889-905
[6]  
Dougherty TJ, 2000, PROG BIOM O, V1, P25
[7]  
Farokhzad O.C., 2006, NANOTECHNOLOGY CANC, P289
[8]  
Freitas RA, 2005, J COMPUT THEOR NANOS, V2, P1
[9]   Nanoparticles for cancer therapy and diagnosis [J].
Fukumori, Y ;
Ichikawa, H .
ADVANCED POWDER TECHNOLOGY, 2006, 17 (01) :1-28
[10]   Methylene blue-encapsulated phosphonate-terminated silica nanoparticles for simultaneous in vivo imaging and photodynamic therapy [J].
He, Xiaoxiao ;
Wu, Xu ;
Wang, Kemin ;
Shi, Bihua ;
Hai, Luo .
BIOMATERIALS, 2009, 30 (29) :5601-5609